Associations between ACE-Inhibitors, Angiotensin Receptor Blockers, and Lean Body Mass in Community Dwelling Older Women

Associations between ACE-Inhibitors, Angiotensin Receptor Blockers, and Lean Body Mass in Community Dwelling Older Women

Studies suggest that ACE-inhibitors (ACE-I) and angiotensin receptor blockers (ARBs) may preserve skeletal muscle with aging. We evaluated longitudinal differences in lean body mass (LBM) among women diagnosed with hypertension and classified as ACE-I/ARB users and nonusers among Women’s Health Init...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jennifer W. Bea, Sylvia Wassertheil-Smoller, Betsy C. Wertheim, Yann Klimentidis, Zhao Chen, Oleg Zaslavsky, Todd M. Manini, Catherine R. Womack, Candyce H. Kroenke, Andrea Z. LaCroix, Cynthia A. Thomson
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Journal of Aging Research
Online Access:	http://dx.doi.org/10.1155/2018/8491092
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Elevated Blood Pressure in the Acute Phase of Stroke and the Role of Angiotensin Receptor Blockers
by: Simona Lattanzi, et al.
Published: (2013-01-01)

Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
by: Wei-Fan Hsu, et al.
Published: (2019-01-01)

Angiotensin I converting enzyme (ACE) inhibitory activity and antihypertensive effects of rice peptides
by: Jingjing Dong, et al.
Published: (2022-11-01)

Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity
by: Evelyn F Okal, et al.
Published: (2025-02-01)

Effect of angiotensin-converting enzyme inhibitors versus that of angiotensin receptor blockers on survival in patients undergoing hemodialysis: a nationwide observational cohort study
by: Seok Hui Kang, et al.
Published: (2024-12-01)

Association between prognosis and the use of angiotensin‐converting enzyme inhibitors and/or angiotensin II receptor blockers in frail patients with heart failure with preserved ejection fraction
by: Akihiro Sunaga, et al.
Published: (2022-06-01)

Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II–Renin Feedback in Hypertensive Patients
by: Yutaka Kawabata, et al.
Published: (2020-01-01)

Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
by: Kazuomi Kario, et al.
Published: (2025-01-01)

Characterization of heart failure patients with reverse left ventricular remodelling post‐angiotensin receptor blockers/neprilysin inhibitors therapy
by: Leonid Maizels, et al.
Published: (2022-06-01)

Genetic Variants of C-5312T REN Increased Renin Levels and Diastolic Blood Pressure Response to Angiotensin Receptor Blockers
by: Mohammad Saifur Rohman, et al.
Published: (2015-01-01)

Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1–7) and Bradykinin
by: Nádia Bertoncello, et al.
Published: (2015-01-01)

Sleep: An unplayed ace in research and treatment of youth with ACEs
by: Sarah L.H. Kamhout, et al.
Published: (2025-04-01)

Systematic Review with Network Meta-Analysis: Comparative Efficacy and Safety of Combination Therapy with Angiotensin II Receptor Blockers and Amlodipine in Asian Hypertensive Patients
by: Dae Wook Lee, et al.
Published: (2019-01-01)

Interaction mechanism of egg white- derived ACE inhibitory peptide TNGIIR with ACE and its effect on the expression of ACE and AT1 receptor
by: Zhipeng Yu, et al.
Published: (2020-03-01)

Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
by: Molly Moore Jeffery, et al.
Published: (2022-07-01)

The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Review and Meta-Analysis
by: Wan-Chuen Liao, et al.
Published: (2025-01-01)

Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1, ACE2, TMPRSS2 expression in hospitalized patients
by: João Locke Ferreira de Araújo, et al.
Published: (2025-01-01)

Bronchial blocker placement for massive hemoptysis
by: Ryan L. Loncar, et al.
Published: (2025-01-01)

Interfacility Transfer for VA-ECMO in Beta Blocker and Calcium Channel Blocker Overdoses: A Report of Two Cases
by: Richard Fisher, et al.
Published: (2025-01-01)

Comparison of Medical Treatments According to the Characteristics of Idiopathic Premature Ventricular Contractions: Beta-blockers or Calcium Channel Blockers?
by: Omer Faruk BAYCAN, et al.
Published: (2023-03-01)

Dwelling in the Digital Age
by: Antoine Picon
Published: (2023-09-01)

Type 2 Diabetes and ADP Receptor Blocker Therapy
by: Matej Samoš, et al.
Published: (2016-01-01)

The ACE2/Apelin Signaling, MicroRNAs, and Hypertension
by: Lai-Jiang Chen, et al.
Published: (2015-01-01)

Distinct Molecular Effects of Angiotensin II and Angiotensin III in Rat Astrocytes
by: Michelle A. Clark, et al.
Published: (2013-01-01)

The Angiotensin-Melatonin Axis
by: Luciana A. Campos, et al.
Published: (2013-01-01)

Sleep quality among sample of Egyptian patients with Alzheimer’s disease: risk factors and role of genetic profiling for ACE, ACE 2 and APO E genotypes
by: Khaled Ahmed Elbeh, et al.
Published: (2025-01-01)

Effects of B-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
by: Al-kuraishy, Hayder M., et al.
Published: (2023)

Rheumatoid Meningoencephalitis: A Feared Condition in the Era of TNF Blockers
by: Fernando Figueroa Rodriguez, et al.
Published: (2018-01-01)

The hearth in the medieval dwelling of Ani
by: Ольга Баева
Published: (2024-12-01)

The Protective Potential Role of ACE2 against COVID-19
by: Fereshteh Golab, et al.
Published: (2023-01-01)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2012-01-01)

LEAN APPLICATIONS IN AN ENGINEERING RESEARCH LABORATORY
by: Jamison V. Kovach, et al.
Published: (2025-03-01)

Subcutaneous Adipose Tissue from Obese and Lean Adults Does Not Release Hepcidin In Vivo
by: Lisa Tussing-Humphreys, et al.
Published: (2011-01-01)

Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis Pigmentosa
by: Mitsuru Nakazawa
Published: (2011-01-01)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
by: Alberto Ferrarese, et al.
Published: (2018-01-01)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
by: Anderson J. Ferreira, et al.
Published: (2012-01-01)

Management of Agitation Following Aneurysmal Subarachnoid Hemorrhage: Is There a Role for Beta-Blockers?
by: Fayaz Ibrahim, et al.
Published: (2012-01-01)

Restricting growth for improved fresh produce scheduling: A role for stomatal blockers?
by: Peter Kettlewell, et al.
Published: (2023-09-01)

Microextraction-Based Techniques for the Determination of Beta-Blockers in Biological Fluids: A Review
by: Styliani Nisyriou, et al.
Published: (2025-01-01)

Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism
by: Yuwen Sheng, et al.
Published: (2025-01-01)